DEVELOPMENT OF A SERUM-FREE CULTURE-MEDIUM FOR THE LARGE-SCALE PRODUCTION OF RECOMBINANT PROTEIN FROM A CHINESE-HAMSTER OVARY CELL-LINE

被引:61
作者
KEEN, MJ
RAPSON, NT
机构
[1] Biology Research Division, Wellcome Research Laboratories, Beckenham, Kent, Langley Court
关键词
INSULIN; FERRIC CITRATE; CHINESE HAMSTER OVARY; DHFR; SERUM-FREE;
D O I
10.1007/BF00749653
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A serum-free medium, WCM5, has been developed for the large scale propagation of CHO (Chinese hamster ovary) cells which express recombinant protein using dihydrofolate reductase as a selectable marker. WCM5 was prepared by supplementing Iscoves medium without lecithin, albumin or transferrin with a number of components which were shown to benefit growth. WCM5 medium contained 5 mg l(-1) human recombinant insulin (Nucellin) but was otherwise protein-free. CHO 3D11* cells which had been engineered to express a humanised antibody, CAMPATH*-1H, were routinely grown using serum-containing medium. From a seeding density of 10(5) cells ml(-1), cells grown in static culture with serum reached a maximal cell density of 6.5 x 10(5) cells ml(-1) after 6 days in culture and produced a maximal antibody concentration of 69 mg l(-1) after 11 days in culture. CHO 3D11* cells grown with serum were washed in serum-free medium then cultured in WCM5 medium. Following a period of adaptation the cell growth and product yield was superior to that achieved with serum-containing medium. CHO cells producing CAMPATH-1H grown in an 8000 l stirred bioreactor seeded with 2 x 10(5) cells ml(-1) reached a maximal viable cell density of 2.16 x 10(6) cells ml(-1) after 108 h in culture and a maximal antibody concentration of 131.1 mg l(-1) after 122 h in culture.
引用
收藏
页码:153 / 163
页数:11
相关论文
共 24 条
[1]  
CAMPISI J, 1984, MOL CELL BIOL, V4, P1809
[2]  
GASSER F, 1985, IN VITRO CELL DEV B, V21, P588
[3]   EXPRESSION OF HUMAN ANTI-TETANUS TOXOID ANTIBODY IN TRANSFECTED MURINE MYELOMA CELLS [J].
GILLIES, SD ;
DORAI, H ;
WESOLOWSKI, J ;
MAJEAU, G ;
YOUNG, D ;
BOYD, J ;
GARDNER, J ;
JAMES, K .
BIO-TECHNOLOGY, 1989, 7 (08) :799-804
[4]   THE CAMPATH-1 ANTIGEN (CDW52) [J].
HALE, G ;
XIA, MQ ;
TIGHE, HP ;
DYER, MJS ;
WALDMANN, H .
TISSUE ANTIGENS, 1990, 35 (03) :118-127
[5]  
HALE G, 1988, LANCET, V2, P1394
[6]   T-CELL DEPLETION WITH CAMPATH-1 IN ALLOGENEIC BONE-MARROW TRANSPLANTATION [J].
HALE, G ;
COBBOLD, S ;
WALDMANN, H .
TRANSPLANTATION, 1988, 45 (04) :753-759
[8]  
HAMILTON WG, 1977, IN VITRO CELL DEV B, V13, P537
[9]  
Handa A, 1987, Dev Biol Stand, V66, P241
[10]  
HOLTTA E, 1983, BIOCHEM J, V210, P945